Join
Live feed
·
INSIDERFilingvia Quantisnow
4D Molecular Therapeutics Inc. logo

Officer Kirn David sold $1,200,851 worth of shares (114,746 units at $10.47) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 942,485 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FDMT (4D Molecular Therapeutics Inc.) and more on Quantisnow.